• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Belen Garijo Sanofi Merck KGaA
Favicon Fierce Pharma

Sanofi ousts Paul Hudson for Merck KGaA chief after 'bumpy ride'

Belén Garijo’s appointment restores a woman CEO to the ranks of the top 10 Big Pharma companies.
Nick Paul Taylor , Fraiser Kansteiner Feb 12, 2026 4:26am
hands

Building biopharma: The communities behind the science

Feb 12, 2026 9:30am
How AI Is reshaping clinical trials and market access
Sponsored

How AI Is reshaping clinical trials and market access

Feb 9, 2026 8:00am
IV drug delivery

Lundbeck’s preventative migraine IV sees success in ph. 2

Feb 12, 2026 1:25pm
Article Primary Image 1jpg
Sponsored

The Data Multiplier Effect: The 4 Forces Changing Biometrics

Feb 9, 2026 8:00am
eraser pencil mistake write cut pen scrub out

Icon reveals accounting investigation, withdraws 2025 guidance

Feb 12, 2026 11:12am
More News

Fierce Biotech Layoff Tracker 2026: Seres, ARPA-H & more

Feb 12, 2026 10:30am

Seres to lay off 30% of employees, pause lead program

Feb 12, 2026 9:55am

Langer-backed biotech looks to end cancer recurrence

Feb 12, 2026 8:00am

BridgeBio preps approval push for dwarfism drug after ph. 3 win

Feb 12, 2026 7:30am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings